IL1B and diabetes mellitus: Since aberrant activation of NLRP3-inflammasome and IL-1 are associated with numerous chronic diseases, including cardiovascular, atherosclerosis and diabetes, the interest in developing or identifying potent and specific NRLP3 inhibitors has been of increased interest [16].